Skip to main content

Table 1 Characteristics of breast cancer patients and controls included in the study

From: Alcohol and breast cancer tumor subtypes in a Spanish Cohort

 

Cases N = 1766 (%)

Controls N = 833 (%)

Age, year

56.3 ± 12.3

53.2 ± 13.2

Age at menarche, year

13.2 ± 1.8

13.0 ± 1.7

Menopausal status

 Postmenopausal

1088 (65.0)

473 (58.0)

 Premenopausal

587 (35.0)

342 (42.0)

Family historya

 No

1459 (84.9)

735 (91.4)

 Yes

259 (15.1)

69 (8.6)

 Age at firts full-term pregnancy, year

24.8 ± 4.9

24.6 ± 5.2

Parity

 No

307 (17.5)

86 (10.5)

 Yes

1443 (82.5)

730 (89.5)

 Number of pregnancies

2.0 ± 1.4

1.9 ± 1.2

Breastfeeding

 No

782 (46.5)

340 (41.7)

 Yes

900 (53.5)

475 (58.3)

 Lifetime breastfeeding, months

6.0 ± 10.8

6.6 ± 11.0

 Body mass index, kg/m2

25.7 ± 4.5

26.6 ± 4.8

Oral contraceptive use

 Never

994 (60.5)

424 (52.1)

 Ever

649 (39.5)

390 (47.9)

Alcohol frequency

 0 drinks/week

752 [46.1]

417 [50.4]

 1–7 drinks/week

607 [37.3]

319 [38.5]

 >7 drinks/week

270 [16.6]

92 [11.1]

Smoking status

 No

1124 [68.2]

542 [65.2]

 Ex-smoker

268 [16.3]

147 [17.7]

 Current smoker

256 [15.5]

142 [17.1]

Hormone replacement therapy

 Never

1456 (90.3)

719 (91.1)

 Ever

156 (9.7)

70 (8.9)

Grade

 I

353 (22.3)

 

 II

808 (51.1)

 

 III

421 (26.6)

 

Histology type

 Ductal invasive

1493 (85.2)

 

 Lobular invasive

164 (9.4)

 

 Other

95 (5.4)

 

Tumor size (2.4 ± 1.6) cm

ER

 Positive

1321 (79.3)

 

 Negative

345 (20.7)

 

PR

 Positive

1093 (66.2)

 

 Negative

559 (33.8)

 

ER/PR/HER2

 ER+/or PR+/HER2−

952 (67.3)

 

 ER+/or PR+/HER2+

178 (12.6)

 

 ER−/PR−/HER2−

204 (14.4)

 

 ER−/PR−/HER2+

80 (5.7)

 
  1. aDefined as one or more first degree relatives with breast and/or ovarian cancer